 The observation period for each patient covered an initial treatment period with Avelox plus optional 2 long-term follow-up periods 6 and 12 months.For each patient, the physician documented data at any initial visit baseline and at least one short-term follow-up visit initial treatment period.Optionally, long-term follow-ups 6 and 12 months were documented, and a patient questionnaire was filled in. 